NSI Equity Snapshot
AUROPHARMA Weekly Equity Report
Aurobindo Pharma Limited
What the company does
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, …
What the weekly tape is saying
AUROPHARMA closed the latest completed week at 1,473 INR. The 4-week return is -2.6% and the 12-week return is 14.0%. Trend Signal is active, Market Dynamics is 1.05. Setup signature: Balanced read with a 67/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,292 INR
- Vs Trend Line
- 14.0%
- Fair Value
- 1,159 INR
- Vs Fair Value
- 27.1%
- 52W High
- 1,550 INR
- 52W Low
- 1,016 INR
- Drawdown
- -5.0%
- Range Position
- 85.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 28 weeks
- 52W Active Weeks
- 28
- 52W Active Breadth
- 53.8%
- Sector Scope
- IN Healthcare
- Sector Rank
- 83 of 161
- Sector Percentile
- 48.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 71 of 100
- Avg 1W
- 2.2%
- Avg 4W
- 5.7%
- Trend Breadth
- 55.0%
- Positive MD
- 90.0%
IN Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 92
- 4W Rank
- 69 of 92
- Avg 1W
- 2.0%
- Avg 4W
- 7.4%
- Trend Breadth
- 50.0%
- Positive RS
- 65.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.05
- 4W MD Change
- -26.3%
- Relative Strength
- 27.46
- 4W RS Change
- -19.0%
- Expectation
- Positive
- Probability
- 56.24%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 4.2M
- 13W Average
- 6.5M
- 52W Average
- 6.4M
- Vs 13W
- 0.6x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.5%
- 52W Volatility
- 3.3%
- Upside Weeks
- 28
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 3.0% / -2.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NSI
- Country
- IN
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- INR
- Market Cap
- 820.7B
Opportunity signals
- Trend Signal is active with a 28-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,473 INR | 0.7% | 1,292 INR | 1,159 INR | 1.05 | 27.46 | 4.2M | On |
| 5 Jun 2026 | 1,462 INR | 2.5% | 1,283 INR | 1,154 INR | 1.23 | 28.74 | 5.6M | On |
| 29 May 2026 | 1,426 INR | -2.5% | 1,272 INR | 1,148 INR | 1.38 | 25.43 | 6.9M | On |
| 22 May 2026 | 1,464 INR | -3.2% | 1,262 INR | 1,144 INR | 1.41 | 28.49 | 7.6M | On |
| 15 May 2026 | 1,512 INR | 1.6% | 1,250 INR | 1,138 INR | 1.42 | 33.90 | 6.0M | On |
| 8 May 2026 | 1,487 INR | 7.0% | 1,236 INR | 1,132 INR | 1.41 | 29.67 | 7.3M | On |
| 1 May 2026 | 1,390 INR | -1.7% | 1,224 INR | 1,126 INR | 1.35 | 22.70 | 4.2M | On |
| 24 Apr 2026 | 1,414 INR | 2.0% | 1,214 INR | 1,121 INR | 1.37 | 25.80 | 7.0M | On |
| 17 Apr 2026 | 1,386 INR | 2.7% | 1,204 INR | 1,116 INR | 1.23 | 21.45 | 7.1M | On |
| 10 Apr 2026 | 1,349 INR | 1.2% | 1,195 INR | 1,111 INR | 1.05 | 20.12 | 8.2M | On |
| 3 Apr 2026 | 1,334 INR | 1.5% | 1,186 INR | 1,106 INR | 0.94 | 26.17 | 6.9M | On |
| 27 Mar 2026 | 1,314 INR | 1.8% | 1,177 INR | 1,101 INR | 0.60 | 24.30 | 7.3M | On |
| 20 Mar 2026 | 1,291 INR | -0.4% | 1,167 INR | 1,096 INR | 0.37 | 21.01 | 6.0M | On |
| 13 Mar 2026 | 1,296 INR | 5.2% | 1,159 INR | 1,091 INR | 0.10 | 21.53 | 10.7M | On |